Department of Pathology

Adrian Suarez, MD

Professor

Adrian Suarez, MD

Phone:

614-293-3884

E-mail:

Email Dr. Suarez

Mailing Address:

James Comprehensive Cancer Center
Room D584
460 W. 10th Ave
Columbus, OH 43210

Biosketch

I am a diagnostic surgical pathologist with expertise in gynecologic pathology and cytopathology. I also have multiple administrative roles within the department of pathology and tissue based research activities. My research focuses on gynecologic malignancies with emphasis on endometrial cancer.

Board Certifications

Anatomic and Clinical Pathology, American Board of Pathology

Academic and Medical Appointments

Professor-Clinical, Department of Pathology, The Ohio State University, Columbus Ohio.

Director of Surgical Pathology

Director of Gynecological Pathology

Education and Training

2003-2004 Cytopathology Fellowship, Washington University School of Medicine, St. Louis, Missouri

2002-2003 Surgical Pathology Fellowship, Washington University School of Medicine, St. Louis, Missouri

1997-2002 Resident, Anatomic and Clinical Pathology, Saint Louis University School of Medicine, St. Louis, Missouri

1996-1997 Resident, Pediatrics, Universidad de Costa Rica, San Jose, Costa Rica

1988-1994 M.D., Universidad de Costa Rica, San Jose, Costa Rica

Selected Publications

Search in PubMed

  • McHugh KE, Reynolds JP, Suarez AA. Postmenopausal Squamous Atypia: Cytologic Features, Hybrid Capture 2 Tests and Contribution to the ASCUS Pool. Acta Cytol. 2018;62(5-6):418-422.
  • Hampel H, Pearlman R, de la Chapelle A, Pritchard CC, Zhao W, Jones D, Yilmaz A, Chen W, Frankel WL, Suarez AA, Cosgrove C, Backes F, Copeland L, Fowler J, O'Malley D, Salani R, McElroy JP, Stanich PP, Goodfellow P, Cohn DE. Double somatic mismatch repair gene pathogenic variants as common as Lynch syndrome among endometrial cancer patients. Gynecol Oncol. 2021 Jan;160(1):161-168. doi: 10.1016/j.ygyno.2020.10.012. Epub 2020 Oct 21. PMID: 33393477; PMCID: PMC7783191.
  • Barrington DA, Felix AS, Owda R, Suarez AA, Cohen DW, Senter L, Copeland LJ, Fowler JM, Backes FJ, Cohn DE, Bixel KL, O'Malley DM, Salani R, Cosgrove CM. Pathologic chemotherapy response score in epithelial ovarian cancer: Surgical, genetic, and survival considerations. Surg Oncol. 2020 Sep;34:40-45. doi: 10.1016/j.suronc.2020.03.001. Epub 2020 Mar 11. PMID: 32891351.
  • Zhang X, Rhoades J, Caan BJ, Cohn DE, Salani R, Noria S, Suarez AA, Paskett ED, Felix AS. Intentional weight loss, weight cycling, and endometrial cancer risk: a systematic review and meta-analysis. Int J Gynecol Cancer. 2019 Nov;29(9):1361-1371. doi: 10.1136/ijgc-2019-000728. Epub 2019 Aug 26. PMID: 31451560; PMCID: PMC6832748.
  • Backes FJ, Cohen D, Salani R, Cohn DE, O'Malley DM, Fanning E, Suarez AA, Fowler JM. Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739). Gynecol Oncol. 2019 Jun;153(3):496-499. doi: 10.1016/j.ygyno.2019.03.252. Epub 2019 Apr 4. PMID: 31230614.
  • Chavez JA, Wei L, Suarez AA, Parwani AV, Li Z. Clinicopathologic characteristics, tumor infiltrating lymphocytes and programed cell death ligand-1 expression in 162 endometrial carcinomas with deficient mismatch repair function. Int J Gynecol Cancer. 2019 Jan;29(1):113-118.
  • Terakawa J, Serna VA, Taketo MM, Daikoku T, Suarez AA, Kurita T. Ovarian insufficiency and CTNNB1 mutations drive malignant transformation of endometrial hyperplasia with altered PTEN/PI3K activities. Proc Natl Acad Sci U S A. 2019 Feb 19.
  • Felix AS, Sinnott JA, Vetter MH, Rhoades J, Cohn DE, Backes FJ, Sherman ME, Suarez AA. Detection of endometrial cancer cells in the fallopian tube lumen is associated with adverse prognostic factors and reduced survival. Gynecol Oncol. 2018 May 10. pii: S0090-8258(18)30893 X.doi:10.1016/j.ygyno.2018.05.005. [Epub ahead of print] PubMed PMID: 29754740
  • Dorayappan KDP, Wanner R, Wallbillich JJ, Saini U, Zingarelli R, Suarez AA, Cohn DE, Selvendiran K. Hypoxia-induced exosomes contribute to a more aggressive and chemoresistant ovarian cancer phenotype: a novel mechanism linking STAT3/Rab proteins. Oncogene. 2018 Apr 11. doi: 10.1038/s41388-018-0189-0. [Epub ahead of print] PubMed PMID: 29636548.
  • Crafton SM, Senter-Jamieson L, Chen JL, Copeland LJ, Suarez AA. Radiation-associated Angiosarcoma Mimicking Fallopian Tube High-grade Serous Carcinoma in a Woman With De Novo Li-Fraumeni Syndrome. Int J Gynecol Pathol. 2018 Apr 3. doi: 10.1097/PGP.0000000000000502. [Epub ahead of print] PubMed PMID: 29620582.
  • Saini U, Suarez AA, Naidu S, Wallbillich JJ, Bixel K, Wanner RA, Bice J, Kladney RD, Lester J, Karlan BY, Goodfellow PJ, Cohn DE, Selvendiran K. STAT3/PIAS3 Levels Serve as "Early Signature" Genes in the Development of High-Grade Serous Carcinoma from the Fallopian Tube. Cancer Res. 2018 Apr 1;78(7):1739-1750. doi: 10.1158/0008-5472.CAN-17-1671. Epub 2018 Jan 16. PubMed PMID: 29339537; PubMed Central PMCID: PMC5907493.
  • Cosgrove CM, Tritchler DL, Cohn DE, Mutch DG, Rush CM, Lankes HA, Creasman WT,Miller DS, Ramirez NC, Geller MA, Powell MA, Backes FJ, Landrum LM, Timmers C, Suarez AA, Zaino RJ, Pearl ML, DiSilvestro PA, Lele SB, Goodfellow PJ. An NRG Oncology/GOG study of molecular classification for risk prediction in endometrioid endometrial cancer. Gynecol Oncol. 2018 Jan;148(1):174-180. doi: 10.1016/j.ygyno.2017.10.037. Epub 2017 Nov 11. PubMed PMID: 29132872; PubMed Central PMCID: PMC5756518
  • Li Z, Joehlin-Price AS, Rhoades J, Ayoola-Adeola M, Miller K, Parwani AV, Backes FJ, Felix AS, Suarez AA. Programmed Death Ligand 1 Expression Among 700 Consecutive Endometrial Cancers: Strong Association With Mismatch Repair Protein Deficiency. Int J Gynecol Cancer. 2018 Jan;28(1):59-68. doi:10.1097/IGC.0000000000001120. PubMed PMID: 29053481.
  • Cohn DE, Backes FJ, Wallbillich JJ, Bixel K, Crafton SM, Neff R, ElNaggar AC, Smith B, Suarez AA. Recurrent low grade serous ovarian cancer in a 20 year old woman: A case from the Ohio State University College of Medicine. Gynecol Oncol. 2017 Mar;144(3):451-455.
  • Saini U, Naidu S, ElNaggar AC, Bid HK, Wallbillich JJ, Bixel K, Bolyard C, Suarez AA, Kaur B, Kuppusamy P, Hays J, Goodfellow PJ, Cohn DE, Selvendiran K. Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic target. Oncogene. 2017 Jan 12;36(2):168-181.
  • Cosgrove CM, Cohn DE, Hampel H, Frankel WL, Jones D, McElroy JP, Suarez AA, Zhao W, Chen W, Salani R, Copeland LJ, O'Malley DM, Fowler JM, Yilmaz A, Chassen AS, Pearlman R, Goodfellow PJ, Backes FJ. Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survival. Gynecol Oncol. 2017 Jul 11. pii: S0090-8258(17)30980-0. doi: 10.1016/j.ygyno.2017.07.003. [Epub ahead of print] PubMed PMID: 28709704.
  • Suarez AA, Joehlin-Price AS. In Reply. Am J Surg Pathol. 2017 Aug;41(8):1150-1151.
  • Suarez AA, Felix AS, Cohn DE. Bokhman Redux: Endometrial cancer "types" in the 21st century. Gynecol Oncol. 2017 Feb;144(2):243-249.
  • Joehlin-Price AS, McHugh KE, Stephens JA, Li Z, Backes FJ, Cohn DE, Cohen DW, Suarez AA. The Microcystic, Elongated, and Fragmented (MELF) Pattern of Invasion: A Single Institution Report of 464 Consecutive FIGO Grade 1 Endometrial Endometrioid Adenocarcinomas. Am J Surg Pathol. 2017 Jan;41(1):49-55.
  • Smith B, Neff R, Cohn DE, Backes FJ, Suarez AA, Mutch DG, Rush CM, Walker CJ, Goodfellow PJ. The mutational spectrum of FOXA2 in endometrioid endometrial cancer points to a tumor suppressor role. Gynecol Oncol. 2016 Nov;143(2):398-405.